Non‐Invasive Urine Markers Differentiate Renal Cancer from Oncocytoma
|
By LabMedica International staff writers Posted on 25 May 2021 |
|
Image: The CHEMOSTAR Touch ECL & Fluorescence Imager (Photo courtesy of INTAS)
Clear cell renal cell carcinoma, (ccRCC), is a type of kidney cancer. Clear cell renal cell carcinoma is also called conventional renal cell carcinoma. Clear cell renal cell carcinoma is named after how the tumor looks under the microscope.
Renal oncocytoma is a benign (noncancerous) growth of the kidney. They generally do not cause any signs or symptoms and are often discovered incidentally while a person is undergoing diagnostic imaging for other conditions. Some people with renal oncocytoma will have abdominal or flank pain; blood in the urine; and/or an abdominal mass.
Urologists at the University Hospital Cologne (Cologne, Germany) have shown that that Vim3 is overexpressed in tissue samples of renal oncocytomas and Mxi‐2 in clear cell renal carcinoma (ccRCC). They collected urine samples from patients suspected of kidney cancer between 2015 and 2018. The final cohort consisted of 350 patients, with pathohistological proof of an oncocytoma in 20 patients or a RCC (50 chromophobe; 40 papillary); 200 clear cell RCC (ccRCC), as well as 40 negative controls.
The medical scientists performed Western blots on urine samples which were analyzed with INTAS Chemostar (Göttingen, Germany). ELISAs were performed using incubated 3B4 Vimentin antibody and for Mxi‐2 and analyzed on the FLUOstar Omega plate reader (BMG LABTECH, Ortenberg, Germany). The team also carried out lateral flow assays; and quantitative real‐time polymerase chain reaction (qRT‐PCR).
The investigators reported that there was a significant increase of Vim3 in urines from patients with oncocytoma and was detectable with ELISA compared to all other subtypes of RCCs. Mxi‐2 was predominantly overexpressed in ccRCCs. Lateral flow assay of Vim3 and Mxi‐2 shows two bands in the case of oncocytoma and ccRCC indicating the specificity of this test. For small renal masses (SRMs), an overexpression of miR‐15a/Mxi2 was detectable in urine samples from ccRCC and chromoRCC patients. In contrast to that, miR‐498/Vim3 were predominantly overexpressed in oncocytoma patients.
The authors concluded that using the highly specific, non‐invasive urine markers, Vim3 and Mxi‐2, they were able to fill the gap and reduce the number of overtreated patients as well as the number of unnecessary surgeries. Furthermore, even the detection as well as pre‐surgical differentiation in small kidney cancers is possible with the measurement of the two predicted miRs as well as the proteins. Both proteins (Vim3 and Mxi‐2) were detectable in patients’ urines and can be used for the non‐invasive differentiation of kidney cancers. The study was published on May 7, 2021 in the Journal of Clinical Laboratory Analysis.
Related Links:
University Hospital Cologne
INTAS
BMG LABTECH
Renal oncocytoma is a benign (noncancerous) growth of the kidney. They generally do not cause any signs or symptoms and are often discovered incidentally while a person is undergoing diagnostic imaging for other conditions. Some people with renal oncocytoma will have abdominal or flank pain; blood in the urine; and/or an abdominal mass.
Urologists at the University Hospital Cologne (Cologne, Germany) have shown that that Vim3 is overexpressed in tissue samples of renal oncocytomas and Mxi‐2 in clear cell renal carcinoma (ccRCC). They collected urine samples from patients suspected of kidney cancer between 2015 and 2018. The final cohort consisted of 350 patients, with pathohistological proof of an oncocytoma in 20 patients or a RCC (50 chromophobe; 40 papillary); 200 clear cell RCC (ccRCC), as well as 40 negative controls.
The medical scientists performed Western blots on urine samples which were analyzed with INTAS Chemostar (Göttingen, Germany). ELISAs were performed using incubated 3B4 Vimentin antibody and for Mxi‐2 and analyzed on the FLUOstar Omega plate reader (BMG LABTECH, Ortenberg, Germany). The team also carried out lateral flow assays; and quantitative real‐time polymerase chain reaction (qRT‐PCR).
The investigators reported that there was a significant increase of Vim3 in urines from patients with oncocytoma and was detectable with ELISA compared to all other subtypes of RCCs. Mxi‐2 was predominantly overexpressed in ccRCCs. Lateral flow assay of Vim3 and Mxi‐2 shows two bands in the case of oncocytoma and ccRCC indicating the specificity of this test. For small renal masses (SRMs), an overexpression of miR‐15a/Mxi2 was detectable in urine samples from ccRCC and chromoRCC patients. In contrast to that, miR‐498/Vim3 were predominantly overexpressed in oncocytoma patients.
The authors concluded that using the highly specific, non‐invasive urine markers, Vim3 and Mxi‐2, they were able to fill the gap and reduce the number of overtreated patients as well as the number of unnecessary surgeries. Furthermore, even the detection as well as pre‐surgical differentiation in small kidney cancers is possible with the measurement of the two predicted miRs as well as the proteins. Both proteins (Vim3 and Mxi‐2) were detectable in patients’ urines and can be used for the non‐invasive differentiation of kidney cancers. The study was published on May 7, 2021 in the Journal of Clinical Laboratory Analysis.
Related Links:
University Hospital Cologne
INTAS
BMG LABTECH
Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Clinical Chemistry System
P780
Latest Clinical Chem. News
- VOCs Show Promise for Early Multi-Cancer Detection
- Portable Raman Spectroscopy Offers Cost-Effective Kidney Disease Diagnosis at POC
- Gold Nanoparticles to Improve Accuracy of Ovarian Cancer Diagnosis
- Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy
- Simple Non-Invasive Hair-Based Test Could Speed ALS Diagnosis
- Paper Strip Saliva Test Detects Elevated Uric Acid Levels Without Blood Draws
- Prostate Cancer Markers Based on Chemical Make-Up of Calcifications to Speed Up Detection
- Breath Test Could Help Detect Blood Cancers
- ML-Powered Gas Sensors to Detect Pathogens and AMR at POC
- Saliva-Based Cancer Detection Technology Eliminates Need for Complex Sample Preparation
- Skin Swabs Could Detect Parkinson’s Years Before Symptoms Appear
- New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
- New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
- Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
- Simple Urine Test Could Detect Multiple Cancers at Early Stage
- Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules
Channels
Molecular Diagnostics
view channel
New Diagnostic Method Detects Pneumonia at POC in Low-Resource Settings
Pneumonia continues to be one of the leading causes of death in low- and middle-income countries, where limited access to advanced laboratory infrastructure hampers early and accurate diagnosis.... Read more
Blood Immune Cell Analysis Detects Parkinson’s Before Symptoms Appear
Early diagnosis of Parkinson’s disease remains one of the greatest challenges in neurology. The condition, which affects nearly 12 million people globally, is typically identified only after significant... Read more
Hematology
view channel
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read more
Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more
Immunology
view channel
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read more
Signature Genes Predict T-Cell Expansion in Cancer Immunotherapy
Modern cancer immunotherapies rely on the ability of CD8⁺ T cells to rapidly multiply within tumors, generating the immune force needed to eliminate cancer cells. However, the biological triggers behind... Read more
Microbiology
view channel
High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read more
Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
Candida bloodstream infections are a growing global health threat, causing an estimated 6 million cases and 3.8 million deaths annually. Hospitals are particularly vulnerable, as weakened patients after... Read more
Pathology
view channel
New Molecular Analysis Tool to Improve Disease Diagnosis
Accurately distinguishing between similar biomolecules such as proteins is vital for biomedical research and diagnostics, yet existing analytical tools often fail to detect subtle structural or compositional... Read more
Tears Offer Noninvasive Alternative for Diagnosing Neurodegenerative Diseases
Diagnosing and monitoring eye and neurodegenerative diseases often requires invasive procedures to access ocular fluids. Ocular fluids like aqueous humor and vitreous humor contain valuable molecular information... Read more
Technology
view channel
Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement
Sorting different cell types—such as cancerous versus healthy or live versus dead cells—is a critical task in biology and medicine. However, conventional methods often require labeling, chemical exposure,... Read more
Embedded GPU Platform Enables Rapid Blood Profiling for POC Diagnostics
Blood tests remain a cornerstone of medical diagnostics, but traditional imaging and analysis methods can be slow, costly, and reliant on dyes or contrast agents. Now, scientists have developed a real-time,... Read more
Industry
view channel
Qiagen Acquires Single-Cell Omics Firm Parse Biosciences
QIAGEN (Venlo, Netherlands) has entered into a definitive agreement to fully acquire Parse Biosciences (Seattle, WA, USA), a provider of scalable, instrument-free solutions for single-cell research.... Read more
Puritan Medical Products Showcasing Innovation at AMP2025 in Boston
Puritan Medical Products (Guilford, ME, USA), the world’s most trusted manufacturer of swabs and specimen collection devices, is set to exhibit at AMP2025 in Boston, Massachusetts, from November 11–15.... Read more
Advanced Instruments Merged Under Nova Biomedical Name
Advanced Instruments (Norwood, MA, USA) and Nova Biomedical (Waltham, MA, USA) are now officially doing business under a single, unified brand. This transformation is expected to deliver greater value... Read more
